Navigation Links
Traumatic Pain Global Clinical Trials Review, H2, 2014
Date:8/25/2014

nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Traumatic Pain 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Clinical Trials by G7 Countries: Proportion of Traumatic Pain to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Traumatic Pain 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Traumatic Pain Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Zambon Company S.p.A. 27

'/>"/>
SOURCE ReportBuyer
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014
2. Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting
3. Ampio Pharmaceuticals subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of companys third US patent for its oxidation-reduction potential diagnostic platform
4. Thomson Reuters Collaborates with One Mind for Research to Advance Traumatic Brain Injury Knowledge
5. SanBio Announces FDA Clearance for the Initiation of a Phase I/2a Clinical Trial Testing Their Cell Therapy Product, SB623, in Patients with Traumatic Brain Injury
6. Neuralstem CEO, Richard Garr, To Participate In Traumatic Brain Injury Panel At BIO International Convention
7. Remedium Technologies Inc. Awarded $500,000 Phase II NSF SBIR Grant to Test Sprayable Foam for Stopping Traumatic Bleeding
8. UCLA Relies on Breakthrough Big Data Technology from IBM To Help Patients with Traumatic Brain Injuries
9. AVANIR PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION WITH DEPARTMENT OF VETERANS AFFAIRS FOR SCREENING PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN VETERANS WITH TRAUMATIC BRAIN INJURY
10. BHR Pharma Investigational Traumatic Brain Injury Treatment Receives European Medicines Agency Orphan Medicinal Product Designation
11. Imaging Shows Some Brains Compensate after Traumatic Injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)...  Quest Diagnostics (NYSE: DGX ), the ... that its Board of Directors has elected Jeffrey M. ... 1, 2014. Including Dr. Leiden, the Board has 11 ... and CEO of Vertex Pharmaceuticals.   Dr. Leiden has ... in the pharmaceutical and biotechnology industries as well as ...
(Date:10/22/2014)... RPh, of Vernak Farms Pharmacy in Skaneateles, ... Roentsch Scholarship by the Professional Compounding Centers of America ... during PCCA,s International Seminar, held October 8-10, ... pharmacist and PCCA member who embodies the innovative and ... pharmacist in the compounding community. George ...
(Date:10/22/2014)... VERNE, Calif. , Oct. 22, 2014 /PRNewswire/ ... readiness products, has developed APLS ® Body ... that minimizes the spread of bacteria and virus ... APLS Body Guard Bio features a rugged, ... finished edges that create a leak-proof inner chamber ...
Breaking Medicine Technology:Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 2Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 3PCCA Awards Charlene Vernak, RPh, the George Roentsch Scholarship 2New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus 2
... , , , ... ) today announced that in a large, randomized, double-blind, placebo-controlled, Phase ... dialysis), anemia and type-2 diabetes (the T rial to ... T herapy, or TREAT), treatment of anemia with Aranesp((R) )(darbepoetin alfa) ...
... , , RIDGEFIELD, Conn., Aug. ... of Long-Term Anticoagulant Therapy, Warfarin, Compared to Dabigatran)(1) study will ... in Barcelona on Sunday, Aug. 30. The primary objective ... the investigational oral direct thrombin inhibitor, dabigatran etexilate, against the ...
Cached Medicine Technology:Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 2Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 3Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 4Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 5Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 6Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 7Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 8Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 2Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 3Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 4Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 5Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 6Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 7
(Date:10/25/2014)... 26, 2014 Top 10 Best SEO ... the world. The site has recently compared many hosting ... HostMonster are among the most reliable Linux web hosting ... Top 10 Best SEO Hosting says, “The hosting suppliers ... companies who outperform their competitors on hosting features, uptime ...
(Date:10/25/2014)... Triton Algae Innovations, ... Dr. Xun Wang has joined the firm as ... Triton has developed a patented synthetic biology platform for ... Dr. Wang, the platform uses algae to produce novel ... “Algae are unique because they can produce compounds that ...
(Date:10/25/2014)... New York (PRWEB) October 25, 2014 ... http://www.thexareltolawsuit.com/ ) will be addressed in December, when the ... next hearing session. According to a Hearing Session Order ... on the matter will be heard on December 4, ... begin at 9:30 a.m. (In Re: Xarelto Products Liability ...
(Date:10/25/2014)... (HealthDay News) -- Arriving home safe and sound is one ... end, be sure that costumes and goody bags have reflective ... an emergency medicine doctor at Meadowlands Hospital Medical Center in ... and costumes should be flame-resistant, Davis said. He offers ... makeup, test it on a small area of skin first ...
(Date:10/25/2014)... 2014 Background: , In 1998 Bob ... is a pioneer in the field of establishing recovery community ... treatment system and when he retired, he set out to ... public service. , 1. Where are the ... them? , 2. Can the recovery community be organized ...
Breaking Medicine News(10 mins):Health News:Top 10 Best SEO Hosting Announces That GreenGeeks.com And HostMonster Are Among The Most Reliable Linux Web Hosting Companies In 2014 2Health News:Triton Algae Innovations Ltd. Names Dr. Xun Wang as President 2Health News:Triton Algae Innovations Ltd. Names Dr. Xun Wang as President 3Health News:Xarelto Lawsuit News: JPML to Hear Oral Arguments on Proposed Xarelto Multidistrict Litigation at December Hearing, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit News: JPML to Hear Oral Arguments on Proposed Xarelto Multidistrict Litigation at December Hearing, Bernstein Liebhard LLP Reports 3Health News:Tips for Safe Trick-or-Treating 2Health News:CCAR Accepting Nominations for the Bob Savage Recovery Advocate of the Year Award 2
... is unfair in dealing with people suffering from cancer. Patients ... pay higher premiums even when they can prove they are ... found that 90 percent of cancer sufferers were being denied ... cancer patients, but anyone with a pre-existing condition is treated ...
... mushrooms along with a variety of other vegetables could ... damage// , the common pathway for cancer, ageing and ... researcher, measured antioxidant capacity in several kinds of mushrooms, ... of which is called the crimini mushroom, or, when ...
... will soon become the first province in Canada to ... of heart failure//. ,The provincial agency in ... in guidelines that allowed accepting donation after cardio-circulatory death ... hundreds. ,This move to permit donations after ...
... rate of transplant surgeries, doctors are rethinking on the ... Committee (AHEC) is deliberating //over the permission for medical ... and on the ventilator, with a motive to remove ... addresses the issue of removal of organs from the ...
... scorpion venom protein showed possibilities of treating brain ... Cambridge have developed a radioactive version of a ... named TM-601, as a safer and different way ... ,Responding to this urgent problem, scientists at ...
... in London created a lot of commotion which led to the ... curable disease and is characterized by cough, phlegm, weight loss, fatigue ... many years. Elizabeth Garrett Anderson and Obstetric Hospital sent letters to ... Hospital. ,Though the health worker was diagnosed to have ...
Cached Medicine News:Health News:Ontario Addresses Shortage of Transplant Organs 2Health News:Brain Cancer Could be Safely Treated with Radioactive Scorpion Venom 2